UlrichSpecksMD
Pulmonology • Rochester, MNCritical Care Medicine, Interstitial Lung Diseases, Pleural Disease
Chair, Division of Pulmonary & Critical Care Medicine, Mayo Clinic Rochester
Dr. Specks is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
200 1st St Sw
Rochester, MN 55905Phone+1 507-284-2511- Is this information wrong?
Education & Training
Mayo Clinic College of Medicine and Science (Rochester)Fellowship, Pulmonary Disease and Critical Care Medicine, 1987 - 1990- Mayo Clinic College of Medicine and Science (Rochester)Residency, Internal Medicine, 1984 - 1986
University of Bonn Faculty of MedicineClass of 1981
Certifications & Licensure
MN State Medical License 1985 - 2024- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Pulmonary Disease
Clinical Trials
- Rituximab for the Treatment of Wegener's Granulomatosis and Microscopic Polyangiitis Start of enrollment: 2005 Jan 01
- Longitudinal Study for Eosinophilic Granulomatosis With Polyangiitis (Churg-Strauss) Start of enrollment: 2006 Apr 01
- Longitudinal Protocol for Granulomatosis With Polyangiitis (Wegener's) and Microscopic Polyangiitis Start of enrollment: 2006 Apr 01
- Join now to see all
Publications & Presentations
PubMed
- Myeloperoxidase-specific antineutrophil cytoplasmic antibody-associated vasculitis.Sabrina Arnold, A Richard Kitching, Veronique Witko-Sarsat, Thorsten Wiech, Sebastian Klapa, Sara Comdühr, Anja Stähle, Antje Müller, Peter Lamprecht, Ulrich Specks> ;The Lancet. Rheumatology. 2024 Mar 28
- Proteinase 3-specific antineutrophil cytoplasmic antibody-associated vasculitis.Erin K O'Brien, Peter Lamprecht, Samuel D Falde, Lynn A Fussner, Henry D Tazelaar, Maximilian F Konig, Ulrich Specks> ;The Lancet. Rheumatology. 2024 Mar 28
- Alveolar Hemorrhage in ANCA-associated Vasculitis: Results of an International, Randomized, Controlled Trial (PEXIVAS).Flores-Suárez, L., Cox, P., Jayne, D., Walsh, M., Fussner, L., Cartin-Ceba, R., Specks, U., Merkel, P.> ;American Journal of Respiratory and Critical Care Medicine. 2024 Feb 12
- Join now to see all
Journal Articles
- Pulmonary Eosinophilic Granulomatosis with Polyangiitis Has IgG4 Plasma Cells and Immunoregulatory FeaturesZachary M Dong, Michael E Wechsler, Praveen Akuthota, Peter A Merkel, Ulrich Specks, Benjamin Raby, Frederic Clayton, The American Journal of Pathology
Other
- Cyclophosphamide pulmonary toxicitySpecks U
http://www.uptodate.com/contents/cyclophosphamide-pulmonary-toxicity
UpToDate, Wolters Kluwer Health - 2012-10-18
Press Mentions
Substudy of ADVOCATE Trial for ANCA-Associated Vasculitis Finds Avacopan Reduces Need for Glucocorticoids, Respiratory and ENT InvolvementMay 9th, 2022- Vasculitis Guidelines in Focus, Part 3: EGPASeptember 14th, 2021
Researchers Identify Possible New Treatment for Severe VasculitisJuly 14th, 2010
Hospital Affiliations
Mayo Clinic Hospital - RochesterRochester, Minnesota
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
